StockData

CPS Technologies vs TechPrecision

CPSH and TPCS side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CPSH and TPCS compare

CPS Technologies is the larger company, worth 1.5 times as much as TechPrecision ($79.5M against $52.7M).

CPS Technologies grew revenue faster over the last twelve months (7.0% versus −0.19% for TechPrecision).

CPS Technologies keeps more of each dollar of sales as profit, with a net margin of 0.32% compared with −3.7% at TechPrecision.

CPS Technologies scores higher on the StockData Score (8 against 4 for TechPrecision), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCPSHTPCS
Size and price
Market cap$79.5M$52.7M
Share price$4.10$5.21
Change, 1 year20.6%18.0%
Change, 5 years−6.2%−31.7%
Beta (5Y)0.820.41
Employees117160
StockData Score
Total score8 (better)4
Valuation score01 (better)
Growth score2 (better)1
Performance score01 (better)
Health score6 (better)1
Dividend score00
Valuation
P/S2.4×1.6× (better)
P/B2.3× (better)6.9×
EV/EBITDA793×26.7× (better)
FCF yield−5.0% (better)−6.1%
Fair value$1.75$5.08
Margin of safety−134%−2.7% (better)
Growth
Revenue growth (TTM)7.0% (better)−0.19%
Revenue growth, 5Y average9.3%15.2% (better)
EPS growth, 5Y average−15.6%–
Profitability
Gross margin15.1%16.0% (better)
Operating margin−1.6% (better)−1.9%
Net margin0.32% (better)−3.7%
FCF margin−12.2%−9.6% (better)
Return on equity0.42% (better)−15.4%
Return on invested capital−3.9% (better)−3.9%
Financial health
Debt / equity0.000.64 (better)
Net debt / EBITDA–2.14
Interest coverage–−1.4×
Current ratio6.44 (better)1.00
Altman Z-score4.01 (better)1.80
Piotroski F-score7 (better)6
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions30.7%18.3%
Held by insiders17.0%15.3%
Insider net buying, 12 months$8.9K–
Short interest, % of float9.1%0.14%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.